Lashonda Charles, LPN | |
10543 S Crater Rd, South Prince George, VA 23805-7333 | |
(804) 431-5585 | |
(804) 431-5820 |
Full Name | Lashonda Charles |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 10543 S Crater Rd, South Prince George, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477012193 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 0002092107 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Lashonda Charles, LPN 10543 S Crater Rd, South Prince George, VA 23805-7333 Ph: () - | Lashonda Charles, LPN 10543 S Crater Rd, South Prince George, VA 23805-7333 Ph: (804) 431-5585 |
News Archive
New research shows that children with Kawasaki Disease remain at an increased risk for cardiovascular events more than 10 years after hospitalization for their condition, highlighting the need for long-term heart disease surveillance and risk reduction strategies for these young patients.
Our DNA, which stores our genetic information, is constantly submitted to damage. If not properly repaired, DNA damage can lead to cell death, which may in turn lead to tissue exhaustion and ageing, or induce mutations resulting in uncontrolled cell proliferation and cancer. Brca1 is a key gene that mediates DNA repair. Mutations in Brca1 lead to familial and sporadic breast and ovarian cancer in humans.
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
An emerging technique designed to quickly distinguish between people with active and dormant tuberculosis may help health professionals diagnose the disease sooner, thereby potentially limiting early exposure to the disease, according to a study conducted by researchers at Duke University Medical Center.
› Verified 7 days ago
Shakema Tucker, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10543 S Crater Rd, South Prince George, VA 23805 Phone: 800-805-6989 | |
Ashley Chambliss, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10543 S Crater Rd, South Prince George, VA 23805 Phone: 804-431-5585 | |
Valerie Deloris Graves, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10543 S Crater Rd, South Prince George, VA 23805 Phone: 804-431-5585 | |
Nak-sha Foster, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10543 S Crater Rd, South Prince George, VA 23805 Phone: 804-431-5585 | |
Miss Tanisha Lewis, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10543 S Crater Rd, South Prince George, VA 23805 Phone: 800-805-6989 | |
Otelia Bryant, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10543 S Crater Rd, South Prince George, VA 23805 Phone: 800-805-6989 |